Improvement of risk assessment in cutaneous melanoma (CM) by a prognostic 31-gene expression profile (31-GEP) test over AJCC-based staging alone

Main Article Content

Giselle Prado
Robert W Cook
Kyle R Covington
Federico A Monzon
Darrell S Rigel

Keywords

Abstract

Abstract not available.

 

Disclosures: Study sponsored by Castle Biosciences.

 

Copyright 2018 SKIN